| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/26/2001 | CN1071570C Extended release, film-coated table of astemizole and pseudoephedrine |
| 09/25/2001 | US6294680 Process for the production of semi synthetic statins via novel intermediates |
| 09/25/2001 | US6294678 Treatment for cancer and compounds for use therewith |
| 09/25/2001 | US6294677 Thiopyran derivatives |
| 09/25/2001 | US6294674 Dibenzofuran sulfonamide matrix metalloproteinase inhibitors |
| 09/25/2001 | US6294673 Mixing methyl 2-(2-nitrobenzylidene) acetoacetate and methyl 3-aminocrotonate in alkanol solvent in absence of catalylst; heating reaction mixture in closed container; isolating nifedipine |
| 09/25/2001 | US6294669 As antibiotic prodrug; for oral administration |
| 09/25/2001 | US6294668 Antibacterial activity against beta-lactam sensitive and resistant gram-positive bacteria, such as staphylococci, pneumococci, and enterococci; used in therapy of infectious diseases caused by those bacteria |
| 09/25/2001 | US6294661 Compounds |
| 09/25/2001 | US6294652 Response regulator |
| 09/25/2001 | US6294586 Administering hydroxyomeprazole or its salt to human for therapy of ulcers |
| 09/25/2001 | US6294585 Treatment of neurodegenerative diseases |
| 09/25/2001 | US6294583 For threrapy of tic disorders, tourette's syndrome, and blepharospasm, and other focal dystonias |
| 09/25/2001 | US6294582 Methods for treatment of asthma using S-oxybutynin |
| 09/25/2001 | US6294581 Inhibition of IgA production |
| 09/25/2001 | US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure |
| 09/25/2001 | US6294579 Method for improving delivery of tyrosine supplementation |
| 09/25/2001 | US6294575 BTK inhibitors and methods for their identification and use |
| 09/25/2001 | US6294574 Compounds and methods for the treatment of inflammatory and immune disorders |
| 09/25/2001 | US6294572 Crystalline N-acetyl neuraminic acid derivatives and process for their preparation |
| 09/25/2001 | US6294569 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject. |
| 09/25/2001 | US6294566 Imidazoline derivatives and uses thereof |
| 09/25/2001 | US6294565 Treatment of leukemia by administering a bisimidazole thiophene |
| 09/25/2001 | US6294564 Benzimidazoles and benzoxazoles |
| 09/25/2001 | US6294563 Protection of nerves and treating glaucoma or ocular hypertension |
| 09/25/2001 | US6294562 Salts of ethyl 3-(2-(4-(4-amino-imino-methyl)phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)acetylamino)-3-phenylpropionate |
| 09/25/2001 | US6294561 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/25/2001 | US6294559 Anticarcinogenic agents |
| 09/25/2001 | US6294558 Antiinflammatory agents and prostaglantins |
| 09/25/2001 | US6294557 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject. |
| 09/25/2001 | US6294556 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/25/2001 | US6294555 1-[(1-Substituted-4-piperidinyl)methyl]-4-piperidine derivative, process for producing the same, medicinal compositions containing the same and intermediates of these compounds |
| 09/25/2001 | US6294553 Method for treating ocular pain |
| 09/25/2001 | US6294552 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 09/25/2001 | US6294551 N-linked sulfonamides of heterocyclic thioesters |
| 09/25/2001 | US6294550 Treatment of female sexual dysfunction |
| 09/25/2001 | US6294549 Method for eliciting an αvβ5 or dual αvβ3/αvβ5 antagonizing effect |
| 09/25/2001 | US6294548 Mixture of indazole, preservative and benzyl alcohol anti-emetic, particularly in the treatment of cytotoxic agent induced emesis, in u.s. |
| 09/25/2001 | US6294546 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 09/25/2001 | US6294544 Blood flow increased in vessels for eyes in mammals |
| 09/25/2001 | US6294542 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 09/25/2001 | US6294540 Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
| 09/25/2001 | US6294538 Antidiabetic agents and diabetic neuropathy, treatment with oxidoreductase enzymes |
| 09/25/2001 | US6294537 Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools |
| 09/25/2001 | US6294533 Calcium channel blockers |
| 09/25/2001 | US6294532 Oxindolylquinazoline derivatives as angiogenesis inhibitors |
| 09/25/2001 | US6294531 Calcilytic compounds |
| 09/25/2001 | US6294530 Heterocyclic compounds for nervous system disorders |
| 09/25/2001 | US6294528 Antibiotics as bactericides |
| 09/25/2001 | US6294526 Bactericides against antibiotic resistant staphylococcus |
| 09/25/2001 | US6294525 Reverse-turn mimetics and methods relating thereto |
| 09/25/2001 | US6294523 Extended type 1 chain glycosphingolipids as tumor-associated antigens |
| 09/25/2001 | US6294522 Compounds for treatment of cardiovascular disorders |
| 09/25/2001 | US6294520 Material for passage through the blood-brain barrier |
| 09/25/2001 | US6294517 Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
| 09/25/2001 | US6294383 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 09/25/2001 | US6294377 Adenoviral vectors of canine origin |
| 09/25/2001 | US6294350 Methods for treating fibroproliferative diseases |
| 09/25/2001 | US6294348 Detection of moduators of signal transduction; incubate sample with modulator and monitor sample for adjustment in signal transduction |
| 09/25/2001 | US6294201 Core, comprising 15 to 35% in weight of a pharmaceutically active substance; 20 to 50% in weight of xanthan; 10 to 30% in weight of a vinyl pyrrolidone--vinyl acetate copolymer |
| 09/25/2001 | US6294199 The dosage is provided by a bilayer tablet. |
| 09/25/2001 | US6294198 Spray-coated with a binder solution, mixed with a disintegrant, and a lubricant, and then compressed into the tablet. |
| 09/25/2001 | US6294197 Known to be effective in the treatment of congestive heart failure and reducing blood pressure. |
| 09/25/2001 | US6294196 Pharmaceutical composition containing diphosphonic acid or salt thereof |
| 09/25/2001 | US6294195 Orally administrable opioid formulations having extended duration of effect |
| 09/25/2001 | US6294194 Improving mass transfer rates, removing soluble compositions from materials. such as capsule mold lubricants, residual solvents, and contaminants from chemical and pharmaceutical containers and preparations, repeatedly modulating the |
| 09/25/2001 | US6294192 Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| 09/25/2001 | US6294190 Antiobestic agent containing procyanidin as the active ingredient |
| 09/25/2001 | US6294188 Ebrotidine, h2 receptor blocker with profound effect on gastric mucus, as a potential contraceptive. |
| 09/25/2001 | US6294186 Antimicrobial compositions comprising a benzoic acid analog and a metal salt |
| 09/25/2001 | US6294178 Aerosol, |
| 09/25/2001 | US6294175 Compounds |
| 09/25/2001 | US6294163 Polymers containing guanidinium groups as bile acid sequestrants |
| 09/25/2001 | US6294151 Diagnosing the infection with urease-generating bacteria, particularly helicobacter pylori. |
| 09/25/2001 | CA2235955C Antiperspirant or deodorant composition with silicone latex |
| 09/25/2001 | CA2214601C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/25/2001 | CA2214051C Beta-lactams useful in preparation of taxols |
| 09/25/2001 | CA2213404C Use of angiogenesis suppressors for inhibiting hair growth |
| 09/25/2001 | CA2059999C Process for preparing 2'-(diethylamino)rifamycin p (p/dea) |
| 09/25/2001 | CA2054559C Process of producing phosphatidylcholine derivatives |
| 09/25/2001 | CA1341296C 2-azabicycloalkane-3-carboxylic acid derivatives, processes for their preparation, agents containing these compounds and their use |
| 09/24/2001 | WO2003006652A2 Inhibition of specific histone deacetylase isoforms |
| 09/24/2001 | CA2408385A1 Inhibition of specific histone deacetylase isoforms |
| 09/24/2001 | CA2341618A1 Proanthocyanidin-containing composition |
| 09/23/2001 | CA2341926A1 Oral formulations of medicaments |
| 09/22/2001 | CA2341344A1 Use of glycogen phosphorylase inhibitors |
| 09/20/2001 | WO2001069252A1 Methods and compositions for the regulation of vasoconstriction |
| 09/20/2001 | WO2001069240A1 Assay for agents that induce chemokinesis |
| 09/20/2001 | WO2001068912A2 Diagnosis of diseases associated with tumor suppressor genes and oncogenes |
| 09/20/2001 | WO2001068911A2 Diagnosis of diseases associated with the cell cycle |
| 09/20/2001 | WO2001068855A2 Gtp-binding protein gamma-12 subunit |
| 09/20/2001 | WO2001068837A2 Antisense oligonucleotides of the human chk1 gene and uses thereof |
| 09/20/2001 | WO2001068828A2 Compositions and methods for regulated protein expression in gut |
| 09/20/2001 | WO2001068722A1 Hydrogel biomedical articles |
| 09/20/2001 | WO2001068721A1 Tissue bulking and coating compositions |
| 09/20/2001 | WO2001068720A1 Embolic compositions |
| 09/20/2001 | WO2001068714A1 Chitosan and method of preparing chitosan |
| 09/20/2001 | WO2001068705A2 Il-17 receptor like molecules and uses thereof |
| 09/20/2001 | WO2001068697A2 Methods and compositions for immunoregulation |
| 09/20/2001 | WO2001068675A2 Treatment of rosacea |